The Lockwood Group, LLC

Healthcare consulting for drug development support

Stamford, Connecticut, United States

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Stamford, ConnecticutHeadquarters
2007Year Founded
ACQUISITIONCompany Stage
Consulting, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.
Pharmaceutical companies developing in-house teams may reduce demand for external services.
Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
Offers strategic publication plans tailored to specific audiences and regulatory standards.
Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.
Rise of personalized medicine creates opportunities for specialized communication strategies.
Integration of AI enhances publication strategies and data analysis capabilities.